Enhanced Anti-Tumor Response Elicited by a Novel Oncolytic Pseudorabies Virus Engineered with a PD-L1 Inhibitor
Article in Viruses (July 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Establishment of canine mammary gland tumor cell lines harboring PI3K/Akt activation as a therapeutic target
Article in BMC Veterinary Research (May 2024)
Anticancer effects of alpelisib on PIK3CA-mutated canine mammary tumor cell lines
Article in Frontiers in Veterinary Science (November 2023)